Recall of TPHA 100

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by BIOMERIEUX.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    In agreement with Afssaps, the company bioMérieux has, on 13/11/2006, recalled several lots of reagent TPHA 100 following the reduction of the title of the positive control (R3) contained in these kits. The users of this device concerned by this defect, in France, have received the attached mail (13/11/2006) (24 KB). This information is intended for laboratory managers, health facility managers and local reactovigilance correspondents for dissemination to the relevant biology departments.


  • Model / Serial
  • Product Description
  • Manufacturer